Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug symbols : Aqst save search
Aquestive Therapeutics Receives FDA Acceptance of New Drug Application (NDA) for Libervant™ (diazepam) Buccal Film in Pediatric Patients and Assignment of Prescription Drug User Fee Act (PDUFA) Date
Published: 2023-09-11 (Crawled : 12:00) - globenewswire.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: -0.67%
H: 11.41%
C: 5.37%
fda drug application therapeutics
Aquestive Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for AQST-109 Epinephrine Oral Film
Published: 2022-02-25 (Crawled : 03:00) - globenewswire.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 7.66%
H: 0.0%
C: 0.0%
aqst-109 new drug fda clearance application drug therapeutics fda clearance epinephrine
Aquestive Therapeutics Receives Written Response to Pre-IND Submission for AQST-109 (epinephrine prodrug sublingual film) and Begins Recruitment for its Epinephrine Film Pharmacokinetic and Safety Trial (EPIPHAST)
Published: 2021-12-13 (Crawled : 21:00) - globenewswire.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: -3.23%
H: 0.0%
C: 0.0%
aqst-109 drug trial therapeutics epinephrine submission
Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergi
Published: 2021-10-25 (Crawled : 13:00) - aquestive.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 1.64%
H: 9.45%
C: 7.6%
treatment epinephrine phase 1 positive topline drug trial merge
Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergic Reactions
Published: 2021-10-25 (Crawled : 13:00) - globenewswire.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 1.64%
H: 9.45%
C: 7.6%
treatment epinephrine phase 1 positive topline drug trial merge
Global Drug Delivery Systems (DDS) Markets 2021-2027 - Increasing R&D Expenditures of Innovator Companies and the Trend of Patent Portfolio Expansion
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
TMO | News | $542.82 0.24% 190K
|
Health Technology
|
| O: 0.62%
H: 0.73%
C: 0.42%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.74%
H: 0.22%
C: -0.41%
CTLT | $56.0 0.36% 56K
|
Health Technology
|
| O: 0.23%
H: 2.96%
C: 2.18%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.4%
H: 0.08%
C: -0.13%
TFFP | $3.135 520
|
Health Technology
|
| O: 2.89%
H: 0.0%
C: -1.57%
LGND | $71.84 -0.94% 8.6K
|
Health Technology
|
| O: -0.09%
H: 1.78%
C: -3.55%
HALO M | $38.44 1.67% 81K
|
Health Technology
|
| O: 0.34%
H: 1.37%
C: -1.63%
ARCT 4 | $26.8 1.82% 44K
|
Health Technology
|
| O: -0.06%
H: 1.09%
C: -6.17%
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 0.57%
H: 1.7%
C: -2.27%
AMGN | $263.65 0.34% 360K
|
Health Technology
|
| O: 0.09%
H: 0.29%
C: -0.82%
expansion drug patent drug delivery liver
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (NDA) Resubmission for Libervant™ (diazepam) Buccal Film
Published: 2021-07-19 (Crawled : 14:00) - globenewswire.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 3.61%
H: 6.98%
C: 4.07%
new drug fda fda acceptance drug submission application resubmission
Aquestive Therapeutics Resubmits New Drug Application for Libervant™ (diazepam) Buccal Film
Published: 2021-06-24 (Crawled : 12:00) - globenewswire.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 3.15%
H: 0.22%
C: -5.68%
new drug drug application
Aquestive Therapeutics to Host Investor & Analyst Virtual Epinephrine Drug Delivery R&D Event on March 25 at 9:00 a.m. ET
Published: 2021-03-05 (Crawled : 12:03) - globenewswire.com
AQST | $4.405 -2.11% 450K
|
Health Technology
|
| O: 6.4%
H: 2.0%
C: -1.78%
epinephrine drug drug delivery liver
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
ZCMD | $2.18 50.35% 24M
|
Commercial Services
CHRO | $1.73 41.22% 46K
|
n/a
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
Your saved searches
Save your searches and get alerts when important news are released.